Watchlist Price Alert

Ligand Pharmaceuticals (LGND)

NASDAQ: LGND · Real-Time Price · USD

114.94

-0.75 (-0.65%)

At close: Jun 27, 2025, 12:39 PM

-0.65% (1D)

Bid	114.76
Market Cap	2.22B
Revenue (ttm)	181.49M
Net Income (ttm)	-132.62M
EPS (ttm)	-7.29
PE Ratio (ttm)	-15.77
Forward PE	16.58
Analyst	Buy

Ask	115.66
Volume	54,845
Avg. Volume (20D)	129,286.3
Open	116.18
Previous Close	115.69
Day's Range	114.03 - 116.18
52-Week Range	81.74 - 129.90
Beta	0.71

About LGND

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol LGND

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for LGND stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

4 months ago

+0.57%

Ligand Pharmaceuticals shares are trading higher a... Unlock content with Pro Subscription

7 months ago

+11.12%

Ligand Pharmaceuticals shares are trading higher after the company reported worse-than-expected Q3 financial results and raised its FY24 guidance.

News

3 days ago · seekingalpha.com

Ligand Pharmaceuticals: Attractive Royalty Model Powers Forward

I maintain my Buy rating on Ligand Pharmaceuticals due to its strong growth trajectory and diversified portfolio. Ligand offers investors exposure to dozens of therapies, reducing risk and increasing ...

1 month ago · seekingalpha.com

Ligand Pharmaceuticals Incorporated (LGND) Q1 2025 Earnings Call Transcript

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Melanie Herman – Executive Director-Investor Relations Todd Davis – Chie...